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Background: Globally, hepatitis B virus (HBV) infection has been identified as one of the most 
common infectious diseases of major health concern. This study was conducted to assess the 
prevalence of Hepatitis B virus infection among Children in selected communities at Riyom L.G.A. of 
Plateau State Nigeria. 
Methodology: Two hundred (200) sera samples were collected from Pupils attending Primary 
Schools at three locations of study and analyzed using the HBs Ag Monolisa ELISA kit and the HBV-
5 panel test for the qualitative assessment of the markers of hepatitis B virus infection in human 
serum, plasma and whole blood. 
Result: Overall result from the total samples assayed showed that, 58(29.0%) were seropositive, [{P 
value of 0.020}: P< 0.05] which indicates statistical significance. considering age of infection, 
children aged 5-9 years recorded a high prevalence of 15.0 %,[{ P value of 0.460}: P > 0.05]. Gender 
consideration of subjects screened showed that male subjects had a prevalence of 19.0% compared to 
10.0% for Females [{P value of 0.0435}: P < 0.05]. Risk factors such as blood transfusion accounted 
for 1.5 %,[{ P value of 0.6138}:P > 0.05]. while subjects with traditional method of circumcision 
recorded a higher prevalence of 9.5% [{P value of 0.3120}:P< 0.05].Considering markers for HBV 
infection, findings showed that the highest rate of positivity recorded with the HBsAg showed 25% 
among children screened, HBeAg recorded 4.0%. Anti-HBs which indicate antibody to the HBsAg 
showed 35(17.5%) positivity while, Anti-HBe positivity recorded 15.0%.Similarly, Anti-HBc 
Positivity showed a record of 13.5% positivity. 
Conclusion: The result obtained from this study showed a higher prevalence of the Hepatitis B Virus 
at our locations of study compared to similar studies conducted earlier within our location of study. It 
is strongly suggested that accurate diagnosis with effective screening of pregnant mothers be 
intensified, while the need for timely vaccination of children at risk be promptly embarked upon.  
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INTRODUCTION 
Hepatitis B virus (HBV) is a 
double stranded circular DNA virus; 
belonging to the family hepadnaviridae. 
[1] 
The virus primarily interferes with the 
functions of the liver by replicating in liver 
cells called the hepatocytes. 
[2] 
Globally it 
causes about 1.2 million deaths per year 
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due to its various complications including 
chronic hepatitis, liver cirrhosis, and liver 
cancer. An estimated 2 billion people have 
been infected with HBV, with 350-400 
million of them remaining chronic carriers 
worldwide,
 [3] 
It has also been estimated 
that 25 - 30% these chronically infected 
persons are at high risk of death from liver 
cirrhosis and cancer (WHO, 2004).
 [4] 
In 
Africa, the number of HBV carriers is 
estimated to be about 50million 
representing about 10-20% of the general 
population and as many as 12.5 million 
will eventually diedue to complications 
from hepatitis B - chronic hepatitis, 




Hepatitis B infection is hyper-
endemic in Nigeria. 
[6,7] 
In children, the 
infection occurs early in life and studies 
report hepatitis B surface antigen (HBsAg) 
prevalence rates of 20%while in adult 
population the rate varies from 10-
38%.Younger age at acquisition of 
infection continues to be the most 
important predictor of chronic carriage and 
those who develop chronic hepatitis B 
have a 15 - 40 %risk of developing the 
complications. 
[8,9] 
This chronicity is being 
due to their immature immune system. 
More than95% of adults spontaneously 
recovers from an acute HBV infection as 
defined by clearance of the HBsAg from 
the blood, an effect that reflects the host’s 
degree of immune response. 
[8,10]
 
Most primary infections are self-
limited with clearance of virus and 
development of immunity. However, an 
estimated 3% to 5% of adults and up to 
95% of children develop chronic HBV 
infection. 
[11] 
In endemic areas, most 
individuals are infected by vertical 
transmission. 
[12]
 In Africa, more than half 
of the population becomes HBV infected 
during their life time and about 8% of 
inhabitants become chronic carriers; most 
of the infections take place during delivery 
or infancy. 
[13]
 Transmission occurs when 
infected blood or body fluid from an 
infected person enters the body of another 
who is not immune. 
[14,15]
 
Africans who are carriers of HBV 
are infected in early childhood, 
predominantly by horizontal transmission 
while Vertical transmission contributes 5-
15% - (occurring more in those with high 
viral load and actively replicating 
virus).Prevention of vertical transmission 
is extremely important since HBV 
infection in early life usually results in a 
chronic carrier state However, for probable 
genetic reasons, HBeAg positivity rates 




The global burden of the disease 
attributable to hepatitis B remains 
enormous, and this is largely due to lack of 
universal vaccination. Although high 
screening rates have been achieved among 
pregnant women, current efforts to identify 
and track infants born to HBsAg-positive 
mothers are inadequate. Advances in the 
prevention of perinatal HBV transmission 
will depend on improved health 
department identification, tracking, and 
case management of infants born to 
HBsAg-positive mothers. 
[17] 
Hepatitis B is 
preventable through vaccination and 
studies have confirmed protection 
following vaccination in both 
industrialized and non-industrialized 
communities. 
[18] 
Hence mass vaccination 
of the population should become 
paramount on a global scale, as this will 
decrease the reservoir of chronic carriers 
able to spread the virus. 
The infectious virus consists of an 
outer envelope - HBsAg, the first 
Seromarker and one of the most useful 
markers of active or chronic hepatitis B 
infection, and an inner core made up of 
Hepatitis B core Antigen (HBcAg), found 
in acute or chronic infections and the e-
antigen (HBeAg), which serves as a 
marker of active viral replication. 
[19,20] 
Serologic markers for the diagnosis of 
Hepatitis B Virus (HBV) infection 
involves measurement of a panel of 
distinct HBV specific antigens and host 
antibodies that react to these antigens. 
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[21,22] 
In general, the panel of responses can 
determine whether a patient is susceptible 
to infection, immune as a result of 
resolved infection, immune as a result of 




MATERIALS AND METHODS 
Study area 
The study was carried out at 
selected communities in Riyom Local 
Government areas of Plateau state, 
Nigeria. 
Ethical consideration 
Ethical approval for this research 
work was sought and obtained from the 
National Blood Transfusion Services 
(NBTS), North central zone Center-
Plateau State Specialist Hospital-Jos 
Nigeria. 
Informed consent 
 Informed consent - both verbal 
and written, were obtained from the child 
and/or the parent (s). They were however 
duly educated on the need for and benefits 
of the study. 
Study Population 
Subjects studied include two 
hundred (200) children aged 0-11years. A 
well-structured questionnaire was designed 
and administered for the study. This was 
used to obtain social and demographic 
information of consenting participants. 
Inclusion and Exclusion criteria 
Subjects who gave informed 
consent through their parents or guardians 
and are asymptomatic by routine 
screening, were included in the study, 
subjects who had once been vaccinated 
with the required three doses of the 
vaccine and those who declined to offer 
consent were excluded from the study.  
Collection and processing of specimens 
Three milllilitre (3ml) of blood 
samples were collected aseptically by 
venipuncture. Each blood sample obtained 
was transferred into a carefully labeled 
plastic microtitre tube containing ethylene 
diaminetetraacetic acid (EDTA) and stored 
in the refrigerator at 4
o
C.Each resultant 
supernatant (Plasma) was carefully 
decanted into a new labeled tube and 
stored at -20°C prior use. 
Laboratory Analysis 
Assay of collected sample was 
carried out by HBsAg ELISA test reagent 
manufactured by Biorad Laboratories. 
Monolisa HBsAg ULTRA assay is a one-
step enzyme Immunoassay technique of 
the “Sandwich” type for the detection of 
the surface antigen of the Hepatitis B virus 
(HBsAg) in the serum or plasma. 
Screening using the 5-panel test kits for 
Serological markers 
HBV-5 panel test for the 
qualitative assessment of the markers of 
hepatitis B virus infection in human serum, 
plasma and whole blood. The HBV Panel 
Test is an Immunochromatographic assay 
method to quickly detect five major 
markers of HBV infections, HBsAg, Anti-
HBs (HBsAb), Anti-HBc (HBcAb), 
HBeAg and Anti-HBe (HBeAb) in human 
blood specimens. 
Statistical analysis 
Data obtained were subjected to 
statistical analysis. Comparison of 
numerical variables between the study 
groups was done using Regression analysis 
to show relationship of the risk factors, the 
confidence intervals and the odd ratios. 
For independent and categorical data, X
2 
tests was performed-value of less than 
0.005 (P<0.005) was considered 
significant. All statistical calculations were 
done using the Graph pad prism statistical 
software and the statistical package for 
social sciences (SPSS) to determine any 
significant relationship between infection 
rate, gender, age and risk factors. 
 
RESULT 
Prevalence of HBV among the 
Children screened showed that Male 
subjects recorded a prevalence of 
(38)19.0% out of the 110(55.0%) subjects 
screened in this category. Compared to 
Females subjects with a prevalence of 
20(10.0%) out of the 90(45.0%) screened, 
showing a statistical significance < 0.005. 
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(Table1). Based on Age, Children aged 5-
9years recorded the highest prevalence of 
30(15.0%).This Prevalence on age of 
subjects in this category was found to be 
statistically insignificant, (Table 2).Risk 
factors among the Children screened 
showed that 19 (9.5%) prevalent was 
recorded among children that had history 
of circumcision with traditional birth 
attendance, this is closely followed by 
those who had their circumcision at Local 
Health Centers with a prevalence of 
15(7.5%).(Table 3). Prevalence of 3(1.5%) 
was recorded among children with history 
of blood transfusion and those with family 
history of HBV Infection. All the risk 
factors are statistically insignificant, 
P>0.005.(Table 4).Considering markers 
for HBV infection, findings showed that 
the highest rate of positivity recorded with 
the HBsAg showed 25% among children 
screened, HBeAgrecorded4.0%. Anti-HBs 
which indicate antibody to the HBsAg 
showed 35(17.5%) positivity while, Anti-
HBe positivity recorded 15.0%.Similarly, 
Anti-HBc Positivity showed a record of 
13.5% positivity) (Table 5). 
 
Table 1: Distributions of Children screened based on Sex 
 Total Number Examined (%) No. Positive (%) No. Negative (%) p-value OR 95%C.I. 
Sex       
Male 110 (55.0) 38 (19.0) 72 (36.0)  1  
Female 90 (45.0) 20 (10.0) 70 (35.0) 0.0435 1.842 0.98-3.48 
 
Table 2: Distributions of Children screened based on Age 
 Total Number Examined (%) No. Positive (%) No. Negative (%) p-value OR 95%C.I. 
Age       
0-4 41 (20.5) 9 (4.5) 32 (16.0)  0.83 0.34-2.05 
5-9 84 (42.0) 30 (15.0) 54 (27.0)  1.64 0.83-3.25 
10-14 75 (37.5) 19 (9.5) 56 (28.0) 0.460 1  
- 
Table 3: Distributions of Children screened based on risk Factors 






p-value OR 95%C.I. 
Exposure to risky lifestyles/behaviors 
Share toothbrush       
Yes 16 (8.0) 3 (1.5) 13 (6.5)    
No 184 (92.0) 55 (27.5) 129 (64.5) 0.5767 0.54 0.15-1.98 
History of circumcision: 
Hospitals/Clinics 14 (7.0) 4 (2.0) 10 (5.0) 0.84  0.23-3.03 
Local Health Centers  37 (18.5) 15 (7.5) 22 (11.0) 1.44  0.61-3.37 
Traditional Birth        
Attendance  59(29.5) 19 (9.5) 40 (20.0)   1  
Uncircumcised 0.(0.0) 0.(0.0) 0.(0.0) 0.3120   
 
Table 4: Distributions of Children screened based on Clinical History. 






p-value OR 95%C.I. 
Clinical history 
Family history of HBV       
Yes 15 (7.5) 3 (1.5) 12 (6.0)  1  
No  185 (92.5) 55 (27.5) 130 (65.0) 0.5816  0.59 0.116-2.18 
Blood transfusion       
Yes 8 (4.0) 3 (1.5) 5 (2.5)  1  
No  192 (96.0) 55 (27.5) 137 (68.5) 0.6138  1.50 0.35-6.47 
Surgery       
Yes 4 (2.0) 2 (1.0) 2 (1.0)  1  
No  196 (98.0) 56 (28.0) 140 (70.0) 0.6280 2.50 0.34-18.19 
Vaccination status       
Yes 15 (7.5) 5 (2.5) 10 (5.0)  1  
No  185 (92.5) 53 (26.5) 132 (66.0) 0.5873 1.25 0.41-8.82 
KEY: OR = Odd ratio.CI = Confidence Interval 
 
Table 5 - Overall Prevalence of HBV markers among children screened 
  HBsAg HBeAg Anti- HBs Anti- HBe Anti- HBc P-Value 
CATEGORY  Results No. (%) No. (%) No. (%) No. (%) No. (%)  
Children Positive 50 (25.0) 8 (4.0) 35 (17.5) 30(15.0) 27(13.5)  
 Negative 159(75.0) 192(96.0 165(82.0 170(85.0) 173(86.5)  
 Total 200(100) 200(100) 200(100) 200(100) 200(100) P<0.0001 
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DISCUSSION 
In this study, two hundred (200) 
children were screened, overall prevalence 
of 58(29.0%) was recorded, which is much 
higher than the outcome of a similar study 
conducted by Ndako et al, 
[24]
 in Kuru 
Community, North-Central Nigeria with a 
prevalence rate of 35(9.7%).Furthermore, 
some studies conducted in Nigeria by 
Sirisena et al, 
[25] 
Bukbuk et al, 
[26]
 
corroborated the increasing prevalence of 
the HBV. 
The value obtained in this study was 
however higher than 7.6% prevalence 
reported in a study among primary school 
children in Nnewi, Nigeria, Chukwuka et al. 
[27]
 and 6.7% among Saudi Arabian children 
Al-Faleh et al
 [28] 
This study also showed a 
higher prevalence compared to a similar 
study among children attending a tertiary 
health institution in Niger Delta, Nigeria by 
Alikor and Erhabor 
[29]
 where 12.4% 
prevalence was recorded. However a much 
more lower prevalence of 4.6% was 
obtained in another study by Uleanya and 
Obidike, 
[30] 
among children attending 
outpatient clinic (CHOP) of the University 
of Nigeria Teaching Hospital, Ituku. 
Age distribution of HBV infection in 
this study showed that, among different age 
groups screened, subjects aged 5-9 had the 
highest prevalence rate of 15.0%,compared 
to 3.9% highest prevalence recorded among 
children aged 7-9 years as obtained in the 
work of Ndako et al, 
[24] 
In a similar study 
by Uleanya and Obidike. 
[30]
 the least 
prevalence was observed among children 
aged 1-5 years (2%) while the highest 
prevalence of HBsAg was observed among 
those aged 6-10 years with (6.5%) 
prevalence. Studies by Sirisena et al
 [25] 
Bukbuk et al, 
[26]
 corroborated the 
increasing prevalence with age and showed 
the overall prevalence to be above 9.7 %.).  
The age of acquiring infection 
remains a major determinant of incidence 
and prevalence rates. It is believed that 
25.0% of children are infected at 1 - 5 years 
of age; while about 1.0 - 5.0% of those 
infected are older children that end up as 
carriers Goldstein [31] These carriers, though 
asymptomatic, might serve as reservoir of 
the virus and medium for spreading 
infection among other children Odusanya. 
[32] 
However, there was no statistical 
significant relationship between age and the 
viral infections in this study. 
 Considering the prevalence of 
HBsAg based on gender, this study showed 
that gender is critical to the acquisition of 
HBV infection. 38(19.0%) of the males 
tested were positive for the infection 
compared to 20(10.0%) females. This is 
similar to the work of Bukbuk et al, 
[26]
 who 
found that HBV antigenaemia was higher 
among male subjects studied with 47.2 % 
positivity compared to female subjects with 
38.1%.Another similarity was observed in 
the work of Isa et al, 
[33]
 who showed that, 
males were more prevalent with hepatitis B 
virus infection with (10%) than their female 
counterparts with (6.7%). However, the 
result obtained from this study disagrees 
with the work of Donbraye et al. 
[34] 
who 
reported a higher female prevalence of 
(15.4%) compared to the male subjects with 
(12.7%). 
Similarly, the result obtained by 
Uleanya and Obidike
 [30] 
recorded a slightly 
higher prevalence of HBsAg among the 
females subjects studied. Gogos et al
 [35] 
concluded that males are known to increase 
the risk of Serum hepatitis infection. This is 
was corroborated by the results obtained 
from this study where risk factor in males 
were considered with regards to the rate of 
HBV infection among male subjects that 
had the traditional method of circumcision 
recorded a higher rate of infection rate 
compared to male that had their 
circumcision in clinics. Though the 
prevalence rates in this study was similar 




 and Bukbuk 
[26]
 who observed a higher 
prevalence among males. Considering risk 
factor, children with history of HBV 
infection in the family recorded 3(1.5%) 
positivity, compared to those without any 
history of HBV infection. Similarly, 
Findings from this work showed that 
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children positive for HBsAg with history of 
HBV infection in the family recorded 
15(7.5%) positivity. This suggests that they 
may have contacted the virus from their 
mother, family members or peer groups. It 
has been shown that children can acquire 
HBV infection during delivery or post -
partum through breast feeding or from 
chronic carrier mothers, Agbede et al 
[38]
 
and through contact among siblings or 




It has been shown that children can 
acquire HBV during delivery or post-
partum, through breast feeding or from 




 added that HBV could be 
transmitted through infected family 
members while children without HBV 
history in the family could have contacted 
the virus from other predisposing factors. 
The social class of the parents in this study 
was not significantly associated with 
HBsAg positivity. This may be because of 
equal exposure to the risk factors of HBV, 
among children of different social classes.  
However, it has been suggested that 
the higher the social class, the lower the 
number of children positive to HBsAg. This 
could be because people in the lower 
socioeconomic class are more likely to 
indulge in activities that may promote 
infection with HBV such as alternative 
medicine, share sharp objects and 




evidence of previous HBV infections varies 
depending on age and socioeconomic class 
Ezegbudo et al 
[41]
 
Other risk factors such as sharing of 
toothbrush among siblings or household 
members16 (8.0%) prevalence rate was 
recorded, this was found to be statistically 
insignificant, however the alkaline nature of 
the saliva may be a contributing factor at 
reducing transmission rate of the virus 
through bite. Meanwhile, an intraoral 
trauma during brushing could be the source 
of transmission; making the chance of 
transmitting the virus through this route is 
likely substantial as such sharing is most 
likely to occur over prolonged time period. 




Liver enzyme analysis on HBsAg 
seropositive subjects 59 (100%), showed 
that 55(93.2%) had normal ALT levels 
while 10(16.9%) had elevated ALT levels. 
This indicates the risk of HBV-related liver 
disease such as hepatocellular carcinoma or 
eventual liver cancer in the nearest future if 
no prompt attention is sought by these 
positive subjects. World health organization 
WHO, 
[43]
 stated that about 25% of adults 
who become chronically infected during 
child hood die from HBV-related liver 
cancer or cirrhosis. Uneke and Ogbu 
[44] 
reported that at the stage of non-replication 
the ALT levels are within the reference 
range while HBsAg may still be actively 
replicating. 
In the study conducted by Tsai et al, 
[45]
 Liver function tests are used to 
determine if the liver has been damaged or 
its function impaired among the children 
that tested positive for the HBV, ALT result 
showed 6.9% abnormality. ALT levels have 
been correlated positively with liver 
inflammation, while patients with 
persistently normal ALT levels had 
significantly lower liver damage compared 
with patients with either intermittent of 
persistently elevated ALT Levels. 
[46] 
Therefore measurement of aminotransferase 
levels by serial observations and analysis 
remain the most common and convenient 
way to identify liver inflammation in 
patients particularly with chronic HBV 
infection.  
From this study the highest rate of 
positivity recorded involved the HBsAg 
with 25% among children. According to Lee
 
[47]
 The presence of HBsAg for longer than 
6 months after acute infection indicates 
chronic infection. The detection of HBsAg 
and absence of IgM anti-HBc in a single 
serum specimen also generally indicates 
chronic HBV infection. Shortly after the 
appearance of the HBsAg, the hepatitis B e 
antigen (HBeAg) generally becomes evident 
                   International Journal of Health Sciences & Research (www.ijhsr.org)  411 
Vol.6; Issue: 4; April 2016 
(Ganem and Prince, 
[48] 
although serum 
HBV DNA assays will show the presence of 
HBV DNA prior to the appearance of 
HBsAg or HBeAg, with HBV DNA levels. 
(Rehermann et al. 
[49] 
The HBeAg recorded 
in this study showed 4.0% among the 
children screened. Previous study reported 
(Yang et al
 [50]
 the presence of HBeAg in 
serum indicate active viral replication.  
The continued presence of HBeAg 
generally reflects higher HBV DNA levels 
and greater infectiousness. Some patients 
with chronic HBV infection may have 
resolution of their HBeAg along with 
appearance of anti-HBe, and this usually 
correlates with low (or absent) HBV levels 
and relatively normal levels of hepatic 
aminotransferase levels Lee. 
[21] 
Anti-HBe 
positivity among the Children screened 
showed a record of 15.0% positivity. Anti-
HBs which indicates antibody to the HBsAg 
showed 35(17.5%) positivity for those 
patients who resolve their infection, HBsAg 
disappears at about 3 to 6 months, often just 
prior to the detection of antibodies to 
hepatitis B surface antigen (anti-HBs). 
The presence of anti-HBs following 
acute infection generally indicates recovery 
and protective \immunity against re-
infection. In addition, patients with 
resolution of infection have disappearance 
of HBeAg and development of antibodies to 
hepatitis B e antigen (anti-HBe). Patients 
with resolved infection have persistence of 
anti-HBc for life, but about 4 to 6 months 
after the appearance of anti-HBc, the total 
anti-HBc predominantly consists of IgG. 
Rehermann, 
[49] 
Earlier studies Zhang et al,
 
[46]
 reported that the history of vaccination 
could be attributed to HBsAb positivity, 
which should increase the confidence of the 
population on immunization process. Anti-
HBc Positivity showed that children 
screened recorded 13.5%, ,while Anti-HBc 
recorded a positivity of 9.3% among 
subjects aged 5-9 years, About the time that 
clinical symptoms develop, antibody to 
hepatitis B core antigen (anti-HBc) appears, 
primarily detectable as the IgM class (IgM 
anti-HBc) Mast et al, 
[51] 
CONCLUSION 
The prevalence rate of Hepatitis B 
virus recorded from this study is alarming 
going by the predisposing risk factors 
outlined which calls for a prompt 
enlightenment on the various risk factors 
that can predispose our study subjects to 
HBV infections. It is most disturbing that 
most parents and guardian of the subjects 
screened had no knowledge of hepatitis B 
virus (HBV), which emphasizes the need for 
public enlightenment campaign coupled 
with routine screening, prompt vaccination 
regimen and management of infected 
individuals, these measures would help 
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